'NHS R&D HTA Programme' -Cover.
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid ar by D. P. M. Symmons. Published by Gray on behalf of NCCHTA in 2005. Publication and catalogue information, links to buy online and reader comments.